Le Lézard
Classified in: Science and technology
Subject: Personnel

LashBack Promotes New Executive Leadership

LashBack, LLC, a leading provider of compliance monitoring, brand protection, and competitive intelligence tools for digital marketers, announced today the promotion of Francis Chmelir to President effective January 1, 2020. Chmelir will assume full responsibility for the operational management, growth initiatives, and strategic direction of LashBack. Peter Wilson, who has led the business for the last seven years, will be leaving LashBack at year-end to pursue other opportunities.

Chmelir has served as LashBack's Vice President of Operations for several years, working closely with LashBack staff and clients, and has taken an increasing role in the leadership and strategic direction of the business. He has a long history of leading growth and innovation having previously served as Executive Director for ITEN, a catalyst for regional technology innovation, and as a founding member for the Technology Entrepreneur Center (TEC), which helped to establish an incubator where more than 100 businesses operate today. A graduate of St. Louis University, Chmelir serves on several non-profit boards and has won multiple awards for his leadership including being selected as a "40-under-40" honoree by the St. Louis Business Journal.

"First and foremost, I want to thank Peter for his leadership and the substantial impact he has made on LashBack," said Chmelir. "During Peter's tenure LashBack experienced record growth, strengthened its technology and business intelligence platform, and expanded its footprint as a trusted partner and service provider to major brands, agencies, networks and publishers." Chmelir continued, "Looking ahead, I am excited to work with our leadership team to continue building on LashBack's strong foundation of proprietary technology and unparalleled compliance expertise."

"Francis is the ideal person to lead LashBack," said Wilson. "He is a talented and experienced leader who is widely-respected by our team and our clients, and he has a clear vision for LashBack's future growth and strategic direction. The business has never been stronger, making now the perfect time for this transition. I look forward to seeing what Francis and the LashBack team accomplish in the coming years."

About LashBack, LLC

LashBack is a leading provider of compliance monitoring, brand protection, and competitive intelligence tools for digital marketers, including major brands, agencies, networks, and publishers. For more than a decade, LashBack has provided unique and actionable insights through its innovative suite of compliance monitoring, brand protection, competitive intelligence, and partner management tools. For more information, please visit www.lashback.com.

These press releases may also interest you

at 16:10
F5 Networks today introduced NGINX Controller 3.0, a cloud-native application delivery solution to help organizations increase business agility, mitigate risk, and enhance their customers' digital experiences. Built to unleash productivity and...

at 16:10
TESSCO TECHNOLOGIES INCORPORATED today reported financial results for its third quarter of fiscal 2020, ended December 29, 2019. Third-Quarter Highlights:         Third Quarter FY 2020   Third Quarter FY 2019  ...

at 16:10
NCR Corporation will release its fourth quarter and full year 2019 financial results after the market close on Tuesday, Feb. 11, 2020. A conference call is scheduled at 4:30 p.m. Eastern Time on the same day. Participants should plan to access the...

at 16:10
Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada for Drax Exametazine® (Kit for the Preparation of Tc99m Exametazime for leukocyte labeling)....

at 16:05
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and year ending December 31, 2019 on Thursday, February 6, 2020, before the U.S. financial markets...

at 16:05
Concert Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Concert. The offering is subject to market...

News published on 4 december 2019 at 18:05 and distributed by: